CGQYX
Price
$13.06
Change
+$0.14 (+1.08%)
Updated
Sep 15 closing price
Net Assets
305.77M
GFFFX
Price
$88.10
Change
+$0.62 (+0.71%)
Updated
Sep 15 closing price
Net Assets
337.84B
Interact to see
Advertisement

CGQYX vs GFFFX

Header iconCGQYX vs GFFFX Comparison
Open Charts CGQYX vs GFFFXBanner chart's image
Columbia Disciplined Growth Inst3
Price$13.06
Change+$0.14 (+1.08%)
VolumeN/A
Net Assets305.77M
American Funds Growth Fund of Amer F2
Price$88.10
Change+$0.62 (+0.71%)
VolumeN/A
Net Assets337.84B
CGQYX vs GFFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGQYX vs. GFFFX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGQYX is a Buy and GFFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 338B vs. CGQYX (306M). GFFFX pays higher dividends than CGQYX: GFFFX (0.51) vs CGQYX (0.00). CGQYX was incepted earlier than GFFFX: CGQYX (10 years) vs GFFFX (17 years). CGQYX (0.85) is less costly to investors than GFFFX (0.40). CGQYX is a more actively managed with annual turnover of: 68.00 vs. GFFFX (25.00). GFFFX has a lower initial minimum investment than CGQYX: GFFFX (250) vs CGQYX (1000000). GFFFX annual gain was more profitable for investors over the last year : 17.20 vs. CGQYX (11.67). GFFFX return over 5 years is better than : 46.95 vs. CGQYX (19.55).
CGQYXGFFFXCGQYX / GFFFX
Total Expense Ratio0.740.40185%
Annual Report Gross Expense Ratio0.850.40213%
Fund Existence10 years17 years-
Gain YTD13.43317.94575%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets306M338B0%
Annual Yield % from dividends0.000.51-
Returns for 1 year11.6717.2068%
Returns for 3 years51.2962.8882%
Returns for 5 years19.5546.9542%
Returns for 10 years45.40105.1043%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO3.590.44
+13.97%
Entero Therapeutics Inc
OVID1.280.02
+1.59%
Ovid Therapeutics
PHIN57.49-0.71
-1.22%
PHINIA
ICLR170.46-4.54
-2.59%
ICON plc
SUPV5.36-0.17
-3.07%
Grupo Supervielle SA